ArticleMethods in molecular biology (Clifton, N.J.)2025
Design and Use of a Microfluidic Device for Oocyte Quality Screening.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oocyte quality is a major factor limiting female fertility. In the context of medically assisted reproduction (MAR), the assessment of oocyte quality is not yet well established, and researchers are screening for characteristics likely to influence pregnancy rate using a wide variety of approaches based on chemistry, -omics, optics, and physical parameters. In this context, microfluidics appears to be a promising technology as it allows the incorporation of multiple sensors on an easy-to-use platform, thus offering practical solutions for oocyte assessment in MAR routines. However, while a variety of microfluidic systems have been established for the manipulation of thousands or millions of cells, few are applicable to single cells of typical oocyte size, limiting the use of microfluidic devices in assisted reproductive technologies. We propose the design of a microfluidic device and a protocol for operating a single oocyte to any sensor integrated into the device and then retrieving it for fertilization. Our approach does not induce morphological alterations in oocytes and is compatible with standard MAR protocols.
Indexed as
Identifiers
40736802What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.